We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

227 hedge funds and large institutions have $1.79B invested in Dr. Reddy's Laboratories in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 97 increasing their positions, 56 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $508K

73% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 56

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

3% more funds holding

Funds holding: 221 → 227 (+6)

3% less capital invested

Capital invested by funds: $1.84B → $1.79B (-$49M)

2.04% less ownership

Funds ownership: 72.32% → 70.28% (-2%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
227
Holders Change
+6
Holders Change %
+2.71%
% of All Funds
3.26%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
29
Increased
97
Reduced
56
Closed
21
Calls
$1.01M
Puts
$508K
Net Calls
+$501K
Net Calls Change
-$463K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$17.1M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$14.7M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$9.71M
4
BlackRock
BlackRock
New York
+$9.17M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$8.59M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$34.4M
2
AIM
Aikya Investment Management
United Kingdom
-$24.3M
3
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$14.6M
4
Millennium Management
Millennium Management
New York
-$13.9M
5
JP Morgan Chase
JP Morgan Chase
New York
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
76
Axiom Investors
Connecticut
$1.84M +$1.86M +115,600 New
Nordea Investment Management
77
Nordea Investment Management
Sweden
$1.84M +$63.2K +3,930 +4%
AAS
78
Avantax Advisory Services
Texas
$1.81M +$5.15K +320 +0.3%
Bank of New York Mellon
79
Bank of New York Mellon
New York
$1.75M -$378K -23,460 -18%
OAC
80
OMERS Administration Corp
Ontario, Canada
$1.72M -$370K -23,000 -18%
TIM
81
Thornburg Investment Management
New Mexico
$1.67M +$1.69M +104,940 New
BG
82
Bellevue Group
Switzerland
$1.64M -$220K -13,665 -12%
BCI
83
Brinker Capital Investments
Pennsylvania
$1.63M +$498K +30,960 +43%
OPS
84
Orion Portfolio Solutions
Nebraska
$1.63M +$498K +30,960 +43%
QCM
85
Quantinno Capital Management
New York
$1.61M +$249K +15,470 +18%
Cerity Partners
86
Cerity Partners
New York
$1.49M +$620K +38,545 +70%
Pathstone Holdings
87
Pathstone Holdings
New Jersey
$1.45M +$45.4K +2,820 +3%
BAMF
88
BI Asset Management Fondsmaeglerselskab
Denmark
$1.45M +$969K +60,240 +194%
RWM
89
Ritholtz Wealth Management
New York
$1.38M +$126K +7,840 +10%
SCM
90
Shelton Capital Management
Colorado
$1.38M -$164K -10,170 -10%
UBS Group
91
UBS Group
Switzerland
$1.37M -$1.59M -99,055 -54%
SEI Investments
92
SEI Investments
Pennsylvania
$1.31M +$291K +18,090 +28%
Victory Capital Management
93
Victory Capital Management
Texas
$1.29M -$20.8K -1,295 -2%
Fidelity Investments
94
Fidelity Investments
Massachusetts
$1.25M +$9.57K +595 +0.8%
SFA
95
Sequoia Financial Advisors
Ohio
$1.24M +$2.9K +180 +0.2%
BP
96
Ballentine Partners
Massachusetts
$1.23M +$180K +11,195 +17%
CG
97
Caprock Group
Idaho
$1.22M +$187K +11,590 +18%
Neuberger Berman Group
98
Neuberger Berman Group
New York
$1.19M +$343K +21,340 +40%
Amundi
99
Amundi
France
$1.18M -$6.68K -415 -0.6%
PA
100
Parallel Advisors
California
$1.16M +$173K +10,750 +17%
2 3
4
5 6

RDY Hedge Fund Activity: Q3 2024 in Review

227 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2024, worth a combined $1.79B — down 2.7% from $1.84B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RDY positions and 21 closed out — a net gain of 8 holders — while 97 added to existing stakes and 56 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $17.1M. The largest seller was Goldman Sachs, cutting an estimated $34.4M.

  • 227 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2024, up from 221 in Q2 2024.
  • Funds reported $1.79B of Dr. Reddy's Laboratories stock for Q3 2024, down 2.7% quarter-over-quarter.
  • 29 funds opened new Dr. Reddy's Laboratories positions in Q3 2024 and 21 closed out, a net change of +8 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2024 was Morgan Stanley, an estimated $17.1M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2024 was Goldman Sachs, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2024.